Marc Labroli

Total Syntheses of Ningalin A, Lamellarin O, Lukianol A, and Permethyl Storniamide A Utilizing Heterocyclic Azadiene Diels−Alder Reactions

Dale L. Boger, Christopher W. Boyce, Marc Labroli et al. · Journal of the American Chemical Society · 1998 · 381 citations

Bioorganic Chemistry, Engineering, Chemoprevention Strategy +21

Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening

Timothy J. Guzi, Kamil Paruch, Michael P. Dwyer et al. · Molecular Cancer Therapeutics · 2011 · 170 citations · Full text

Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. IV. Discovery of 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-{2-methoxy-1(<i>R</i>)-4-(trifluoromethyl)phenyl}ethyl-3(<i>S</i>)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a Potent, Highly Selective, and Orally Bioavailable CCR5 Antagonist

Jayaram R. Tagat, Stuart W. McCombie, Dennis V. Nazareno et al. · Journal of Medicinal Chemistry · 2004 · 136 citations · Full text

Excellent Receptor Selectivity, Immunology, Hiv-1 Inhibitors +19

TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci

Sang Ho Lee, Hao Wang, Marc Labroli et al. · Science Translational Medicine · 2016 · 108 citations

The synthesis of amino-acid functionalized β-Carbolines as topoisomerase II inhibitors

Amy M. Deveau, Marc Labroli, Christine M. Dieckhaus et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 102 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Biochemistry +9